1
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Methylenetetrahydrofolate reductase gene polymorphisms in black South Africans and the association with preeclampsia

, , , &
Pages 449-454 | Published online: 10 Aug 2009

References

  • Department of Health. Saving Mothers 1999–2001: Report of the National Committee on Confidential Enquiries into Maternal Deaths in South Africa. Pretoria: Department of Health, 2003.
  • Dekker GA, Vries JIP, Doelitzsch PM, Huijgens PC, van Blumberg BME, Jacobs C et al. Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gynecol 1995; 173: 1042–8.
  • Powers RW, Evans RW, Majors AK, Ojimba JI, Ness RB, Crombelholme WR et al. Plasma homocysteine concentration is increased in preeclampsia and is associated with evidence of endothelial activation. Am J Obstet Gynecol 1998; 179: 1605–11.
  • Clarke R, Daly L, Robinson K. Hyperhomocysteinaemia: an independent risk factor for vascular disease. N Engl J Med 1991; 324: 1149–55.
  • Rajkovic A, Catalano PM, Malinow MR. Elevated homocys-t(e)ine levels with pre-eclampsia. Obstet Gynecol 1997; 90: 168–71.
  • Wang J, Trudinger BJ, Duarte N, Wilcken DE, Wang X. Elevated circulating homocyst(e)ine levels in placental vascular disease and associated preeclampsia. Br J Obstet Gynaecol 2000; 107: 935–8.
  • Lachmeijer AMA, Arngrimsson R, Bastiaans EJ, Pals G, Kate LP, Vries JIP et al. Mutations in the gene for methylenetetrahy- drofolate reductase, homocysteine levels and vitamin status in women with a history of preeclampsia. Am J Obstet Gynecol 2001; 184: 394–402.
  • Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews R et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111–13.
  • Van der Put NM, Gabreels F, Stevens EM, Steitink JA, Trijebls FJ, Eskes TK et al. A second mutation in the methylenetetrahy- drofolate reductase gene: an additional risk factor for neutral tube defects? Am J Hum Genet 1998; 62: 1044–51.
  • Weisberg I, Tran P, Christensen B, Sibani S, Rosen R. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Gen Metab 1999; 64: 169–72.
  • Grandone E, Margaglione M, Colaizzo D, Cappucci G, Paladini D, Martinelli P et al. Factor V Leiden, C → T MTHFR polymorphism and genetic susceptibility to preeclampsia. Thromb Haem 1997; 77: 1052–4.
  • Sohda S, Arimani T, Hamada H, Yamada N, Hamaguchi H, Kubo T. Methylenetetrahydrofolate reductase polymorphisms and preeclampsia. J Med Genet 1997; 34: 525–6.
  • Nagy B, Rigo J, Toth T, Karadi I, Romics L, Papp Z. Methy-lenetetrahydrofolate reductase polymorphisms in healthy pregnant and preeclamptic women. Clin Chem 1998; 44: A15.
  • Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999; 340: 9–13.
  • Powers RW, Minich LZ, Lykins DL, Ness RB, Crombleholme WR, Roberts JM. Methylenetetrahydrofolate reductase polymorphism, folate and susceptibility to preeclampsia. J Soc Gynecol Invest 1999; 6: 74–9.
  • Kaiser T, Brenneke T, Moses EK. Methylenetetrahydrofolate reductase polymorphisms are not a risk factor for preeclampsia/ eclampsia in Australian women. Gynecol Obstet Invest 2000; 50: 100–2.
  • Laivuori K, Kaaja R, Ylikorkata O, Hiltunen T, Kontula K. 677C → T polymorphism of the methylenetetrahydrofolate reductase gene and preeclampsia. Obstet Gynecol 2000; 96: 277–80.
  • Chikosi AB, Moodley J, Pegoraro RJ, Lanning PA, Rom L. 5,10 methylenetetrahydrofolate reductase polymorphism in black South African women with preeclampsia. Br J Obstet Gynaecol 1999; 106: 1216–20.
  • Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human cells. Nucleic Acid Res 1988; 16: 1215.
  • Zusterzeel PL, Visser W, Blom HJ, Peters WH, Heil SG, Steegers EA. Methylenetetrahydrofolate reductase polymorphisms in preeclampsia and the HELLP syndrome. Hyperten Preg 2000; 19: 299–307.
  • Franco RF, Araujo AG, Guerriro JF, Elion J, Zago MA. Analysis of the 677C → T mutation of methylenetetrahydrofolate reductase gene in different ethnic groups. Thromb Haem 1998; 79: 119–21.
  • Kobashi G, Yamada H, Asano T, Nagano S, Hata A, Kishi R et al. Absence of association between a common mutation in the methylenetetahydrofolate reductase gene and preeclampsia in Japanese women. Am J Med Genet 2000; 93: 122–5.
  • Kim YJ, Williamson RA, Murray JC, Andrews J, Pietscher JJ, Peraud PJ et al. Genetic susceptibility to preeclampsia: roles of cytosine-to-thymine substitution at nucleotide 677 for methylenetetrahydrofolate reductase, 68-base pair insertion at nucleotide 844 of the gene for cystathionine beta synthase, and factor V Leiden mutation. Am J Obstet Gynecol 2001; 184: 1211–17.
  • Rosenberg N, Murata M, Ikeda Y, Opare-Sem O, Zivelin A, Geffen E et al. The frequent 5,10-methylenetetrahydrofolate reductase C677T polymorphism is associated with a common haplotype in Whites, Japanese, and Africans. Am J Hum Genet 2002; 70: 758–62.
  • Friso S, Choi SW, Girelli D, Mason JB, Dolnikowski GG, Bagley PJ et al. A common mutation in the 5,10-methylenete- trahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci 2002; 99: 5601–11.
  • The International SNP Map Working Group. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 2001; 409: 928–33.
  • Hoffmeyer S, Burk O, von Richter O, Arnold HP, Brockmoller J, Johne A et al. Functional polymorphisms in the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA 2000; 97: 3473–8.
  • Gambaro G, Anglani F, D’Angelo A. Association studies in genetic polymorphisms and complex disease. Lancet 2000; 255: 308–11.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.